Skip to content
2000
Volume 8, Issue 8
  • ISSN: 1389-5575
  • E-ISSN: 1875-5607

Abstract

Recently, Canadian, US and European health regulatory agencies issued warnings about an increased risk of stroke and death in elderly patients with dementia receiving atypical antipsychotics. Assessing both randomised and nonrandomised evidence, this systematic review found conflicting findings, particularly for risperidone. More research is needed to better inform clinical practice.

Loading

Article metrics loading...

/content/journals/mrmc/10.2174/138955708784912175
2008-07-01
2025-09-10
Loading full text...

Full text loading...

/content/journals/mrmc/10.2174/138955708784912175
Loading
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test